165 related articles for article (PubMed ID: 31522881)
21. Rectum Dose Constraints for Carbon Ion Therapy: Relative Biological Effectiveness Model Dependence in Relation to Clinical Outcomes.
Choi K; Molinelli S; Russo S; Mirandola A; Fiore MR; Vischioni B; Fossati P; Petrucci R; Turturici I; Dale JE; Valvo F; Ciocca M; Mairani A
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31877802
[TBL] [Abstract][Full Text] [Related]
22. Mapping of RBE-weighted doses between HIMAC- and LEM-Based treatment planning systems for carbon ion therapy.
Steinsträter O; Grün R; Scholz U; Friedrich T; Durante M; Scholz M
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):854-60. PubMed ID: 22483698
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity study of the microdosimetric kinetic model parameters for carbon ion radiotherapy.
Dahle TJ; Magro G; Ytre-Hauge KS; Stokkevåg CH; Choi K; Mairani A
Phys Med Biol; 2018 Nov; 63(22):225016. PubMed ID: 30418940
[TBL] [Abstract][Full Text] [Related]
24. Impact of enhancements in the local effect model (LEM) on the predicted RBE-weighted target dose distribution in carbon ion therapy.
Grün R; Friedrich T; Elsässer T; Krämer M; Zink K; Karger CP; Durante M; Engenhart-Cabillic R; Scholz M
Phys Med Biol; 2012 Nov; 57(22):7261-74. PubMed ID: 23075883
[TBL] [Abstract][Full Text] [Related]
25. EUD-based biological optimization for carbon ion therapy.
Brüningk SC; Kamp F; Wilkens JJ
Med Phys; 2015 Nov; 42(11):6248-57. PubMed ID: 26520717
[TBL] [Abstract][Full Text] [Related]
26. Understanding Relative Biological Effectiveness and Clinical Outcome of Prostate Cancer Therapy Using Particle Irradiation: Analysis of Tumor Control Probability With the Modified Microdosimetric Kinetic Model.
Besuglow J; Tessonnier T; Mein S; Eichkorn T; Haberer T; Herfarth K; Abdollahi A; Debus J; Mairani A
Int J Radiat Oncol Biol Phys; 2024 Feb; ():. PubMed ID: 38423224
[TBL] [Abstract][Full Text] [Related]
27. Fast Biological Modeling for Voxel-based Heavy Ion Treatment Planning Using the Mechanistic Repair-Misrepair-Fixation Model and Nuclear Fragment Spectra.
Kamp F; Cabal G; Mairani A; Parodi K; Wilkens JJ; Carlson DJ
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):557-68. PubMed ID: 26460998
[TBL] [Abstract][Full Text] [Related]
28. Assessment of potential advantages of relevant ions for particle therapy: a model based study.
Grün R; Friedrich T; Krämer M; Zink K; Durante M; Engenhart-Cabillic R; Scholz M
Med Phys; 2015 Feb; 42(2):1037-47. PubMed ID: 25652516
[TBL] [Abstract][Full Text] [Related]
29. Extension of matRad with a modified microdosimetric kinetic model for carbon ion treatment planning: Comparison with Monte Carlo calculation.
Yoon E; Kim JI; Park JM; Choi CH; Jung S
Med Phys; 2023 Sep; 50(9):5884-5896. PubMed ID: 37162309
[TBL] [Abstract][Full Text] [Related]
30. Results of a prospective randomized trial on long-term effectiveness of protons and carbon ions in prostate cancer: LEM I and α/β = 2 Gy overestimates the RBE.
Eichkorn T; Karger CP; Brons S; Koerber SA; Mielke T; Haberer T; Debus J; Herfarth K
Radiother Oncol; 2022 Aug; 173():223-230. PubMed ID: 35714806
[TBL] [Abstract][Full Text] [Related]
31. Effects of beam interruption time on tumor control probability in single-fractionated carbon-ion radiotherapy for non-small cell lung cancer.
Inaniwa T; Kanematsu N; Suzuki M; Hawkins RB
Phys Med Biol; 2015 May; 60(10):4105-21. PubMed ID: 25933161
[TBL] [Abstract][Full Text] [Related]
32. Radiobiological issues in prospective carbon ion therapy trials.
Fossati P; Matsufuji N; Kamada T; Karger CP
Med Phys; 2018 Nov; 45(11):e1096-e1110. PubMed ID: 30421806
[TBL] [Abstract][Full Text] [Related]
33. Validation of the relative biological effectiveness of active-energy scanning carbon-ion radiotherapy on a commercial treatment planning system with a microdosimetic kinetic model.
Wang W; Sun W; Shen H; Zhao J
Radiat Oncol; 2023 May; 18(1):82. PubMed ID: 37198685
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous optimization of RBE-weighted dose and nanometric ionization distributions in treatment planning with carbon ions.
Burigo LN; Ramos-Méndez J; Bangert M; Schulte RW; Faddegon B
Phys Med Biol; 2019 Jan; 64(1):015015. PubMed ID: 30523890
[TBL] [Abstract][Full Text] [Related]
35. Development and Validation of Single Field Multi-Ion Particle Therapy Treatments.
Kopp B; Mein S; Dokic I; Harrabi S; Böhlen TT; Haberer T; Debus J; Abdollahi A; Mairani A
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):194-205. PubMed ID: 31610250
[TBL] [Abstract][Full Text] [Related]
36. Technical note: Impact of beamline-specific particle energy spectra on clinical plans in carbon ion beam therapy.
Resch AF; Schafasand M; Lackner N; Niessen T; Beck S; Elia A; Boersma D; Grevillot L; Fossati P; Glimelius L; Stock M; Georg D; Carlino A
Med Phys; 2022 Jun; 49(6):4092-4098. PubMed ID: 35416302
[TBL] [Abstract][Full Text] [Related]
37. The sensitivity of radiobiological models in carbon ion radiotherapy (CIRT) and its consequences on the clinical treatment plan: Differences between LEM and MKM models.
Góra J; Grosshagauer S; Fossati P; Mumot M; Stock M; Schafasand M; Carlino A
J Appl Clin Med Phys; 2024 Mar; ():e14321. PubMed ID: 38436509
[TBL] [Abstract][Full Text] [Related]
38. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
Traneus E; Ödén J
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
[TBL] [Abstract][Full Text] [Related]
39. Interlaced proton grid therapy - Linear energy transfer and relative biological effectiveness distributions.
Henry T; Ödén J
Phys Med; 2018 Dec; 56():81-89. PubMed ID: 30473384
[TBL] [Abstract][Full Text] [Related]
40. Biological dose optimization incorporating intra-tumoural cellular radiosensitivity heterogeneity in ion-beam therapy treatment planning.
Inaniwa T; Kanematsu N; Koto M
Phys Med Biol; 2024 May; 69(11):. PubMed ID: 38636504
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
